Axtria Leads Frost & Sullivan’s First Pharmaceutical Commercialization Solutions and Services Industry Radar Report
BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ -- Axtria Inc., a global…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial
December 12, 2024 06:00 ET | Source: Keros Therapeutics, Inc. Keros will…
BC Platforms-Nottingham Partnership to Power World-Leading University and Hospital Data-Sharing and Research
New contract with the University of Nottingham and Nottingham University Hospitals NHS…
5th Anniversary: ICPO Foundation is empowering a new era of cancer treatment with Radiotheranostics for patients worldwide
Launching the "ICPO Academy for Theranostics" and creating its global network of…
A public organisation has chosen the Aino SaaS platform
December 12, 2024 02:30 ET | Source: Aino Health AB (publ) Yet…
Essential Pharma announces 900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street
Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle…
THERME GROUP ACQUIRES THERME ERDING AND SECURES 320 MILLION FINANCING, TO CREATE THE WORLD’S LARGEST WELLBEING INFRASTRUCTURE PLATFORM
The Acquisition of Europe's Largest Wellbeing Destination, Backed by One of the…
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz
** IND submitted to the FDA showing significantly improved patient condition when…
Kraig Biocraft Laboratories Reports Record-Setting Recombinant Spider Silk Production in 2024
ANN ARBOR, Mich., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories,…
